• Print

people/breastwithrose.jpgEvery thirty seconds, somewhere in the world a woman is diagnosed with breast cancer. For women at increased risk of developing breast cancer, preventing the disease is being viewed as a possibility. Now, a study is looking at a medicine to actually help prevent breast cancer.

The National Cancer Institute of Canada Clinical Trials Group is looking for women to take part in ExCel, a research study supported in part by Pfizer.Study Chair Dr. Paul Goss describes the importance of this study. “This study is investigating a newer targeted therapy that may offer a potential alternative to - and advantage - over Tamoxifen, the only drug approved in breast cancer prevention.&rdquoPostmenopausal women thirty-five or older who have an increased risk for developing breast cancer are eligible to enroll. For more information, log onto excelstudy.com or call 1-800-4-CANCER, or 1-800-422-6237.